0000905718-17-000497.txt : 20170427 0000905718-17-000497.hdr.sgml : 20170427 20170427172453 ACCESSION NUMBER: 0000905718-17-000497 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20170427 DATE AS OF CHANGE: 20170427 EFFECTIVENESS DATE: 20170427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NAM Biotech Fund II, LLC - Series II CENTRAL INDEX KEY: 0001704222 IRS NUMBER: 821035093 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285671 FILM NUMBER: 17790387 BUSINESS ADDRESS: STREET 1: 410 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-417-8033 MAIL ADDRESS: STREET 1: 410 PARK AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001704222 NAM Biotech Fund II, LLC - Series II 410 PARK AVENUE, 14TH FLOOR NEW YORK NY NEW YORK 10022 212-417-8033 DELAWARE None None Limited Liability Company true 2017 - NAM Biotech Management LLC 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 Executive Officer Manager - National Asset Management, Inc. 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 Executive Officer Advisor David Levine c/o National Asset Management, Inc. 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false true false true false 0 National Securities Corporation 7569 None None ONE UNION SQUARE, 600 UNIVERSITY STREET SUITE 2900 SEATTLE WA WASHINGTON 98101 All States false 40000000 0 40000000 false 0 4000000 true 0 true Assumes maximum commissions earned equal to 10% of gross proceeds. Excludes 5-year cash only placement agent warrants as set forth in the offering materials. 0 true false NAM Biotech Fund II, LLC - Series II /s/ David Levine David Levine Authorized Signatory 2017-04-27